csl

2020 was a watershed year for biotech companies around the world. The combination of urgent need, commitment and massive government support saw the huge benefits of research and development on show, when not one but multiple companies produced vaccines for the Coronavirus. Extensive coverage of the sector generated huge enthusiasm for it, with many stocks…

ASX finishes flat, CSL (ASX:CSL), Wesfarmers (ASX:WES) delivers again, Fortescue (ASX:FMG) delivers record dividend The ASX200 (ASX:XJO) finished flat for the day, but with growing dispersion in underlying company performance. Treasury Wine (ASX:TWE) lead the way, jumping 17.5%, but it was healthcare company CSL (ASX:CSL) that contributed most with the consumer discretionary (+0.6%) and the healthcare (+2.0%) the few winners. Unemployment…

Markets to open higher, ASX up 1.3% on the back of CSL (ASX: CSL), National Australia Bank (ASX: NAB) profit crushed, ‘Nirvana’ for sharemarkets. The ASX 200 (ASX: XJO) delivered another strong day as it became more clear that Joe Biden would be the next President of the United States. Despite the election still being…

Victorian lockdowns extended, markets remain calm, Labor Day holiday in the US, ASX to open higher

In the latest of our never sell stocks, is one of Australia’s true global leaders, CSL, or Commonwealth Serum Laboratories. The company was founded in 1916 and was actually part of the Federal Government at the time. CSL is a biopharmaceutical company that researches, develops, manufactures and markets products to treat and prevent human medical…